Showing results (1-10 of 264) with videos related to
Sort By:
Pageof 27
Digestive Diseases (Basel, Switzerland)|March 6, 2010
Experimental models of stress and pain: do they help to develop new therapies?Sylvie Bradesi, Emeran A MayerExpert Opinion on Pharmacotherapy|November 5, 2003
Alosetron and irritable bowel syndromeEmeran A Mayer, Sylvie BradesiCurrent Opinion in Pharmacology|November 17, 2007
Novel therapeutic approaches in IBSSylvie Bradesi, Emeran A MayerCurrent Opinion in Pharmacology|September 13, 2008
Visceral analgesics: drugs with a great potential in functional disorders?Sylvie Bradesi, Jeremy Herman, Emeran A MayerCurrent Gastroenterology Reports|July 17, 2003
Current insights into the pathophysiology of irritable bowel syndromeInes Schwetz, Sylvie Bradesi, Emeran A MayerExpert Review of Gastroenterology & Hepatology|February 12, 2011
The role of experimental models in developing new treatments for irritable bowel syndromeDaniel P Holschneider, Sylvie Bradesi, Emeran A MayerNeuroimmunomodulation|October 12, 2012
Chronic stress-induced changes in pro-inflammatory cytokines and spinal glia markers in the rat: a time course studyViktoriya Golovatscka, Helena Ennes, Emeran A Mayer, et al.Current Opinion in Gastroenterology|February 11, 2005
Inflammatory bowel disease and irritable bowel syndrome: separate or unified?Sylvie Bradesi, James A McRoberts, Peter A Anton, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|November 27, 2008
Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in ratsSylvie Bradesi, Vicente Martinez, Lijun Lao, et al.Gastroenterology|March 3, 2009
Role of spinal microglia in visceral hyperalgesia and NK1R up-regulation in a rat model of chronic stressSylvie Bradesi, Camilla I Svensson, Joanne Steinauer, et al.Pageof 27